Kalyra Pharmaceuticals, Inc.
Biotechnology company · San Diego, California, United States
Kalyra Pharmaceuticals, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2012. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $3.1 million in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $6.2 million sold in a notice filed in 2013.
Kalyra Pharmaceuticals at a glance
What does Kalyra Pharmaceuticals do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $3.1 million in total (2015 to 2016). NIH funding came from the National Cancer Institute, National Institute on Drug Abuse, National Institute of General Medical Sciences.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $6.2 million sold (2013).
Frequently asked questions about Kalyra Pharmaceuticals
Where is Kalyra Pharmaceuticals headquartered?
Kalyra Pharmaceuticals, Inc. is headquartered in San Diego, California, United States.
What does Kalyra Pharmaceuticals do?
Kalyra Pharmaceuticals, Inc. is a biotechnology company.
When was Kalyra Pharmaceuticals founded?
The earliest incorporation on record for Kalyra Pharmaceuticals, Inc. is in 2012, according to public company registers.
Similar companies
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
- ImageneBio, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences